|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.580 CAD | -1.20% |
|
-1.20% | -1.79% |
| Apr. 06 | InnoCan Pharma Corporation announced that it has received $0.2 million in funding | CI |
| Mar. 31 | InnoCan Pharma Corporation announced that it expects to receive $0.2 million in funding | CI |
EPS & Dividend: InnoCan Pharma Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3.993 | -2.908 | -0.9828 | -1.189 | -0.4257 | -0.2511 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 17.089 | 41.091 | 10.326 | 15.258 | 9.487 | 4.896 |
| Nbr of stocks (in thousands) | 2,870 | 3,823 | 3,842 | 4,123 | 4,414 | 4,499 |
| Announcement Date | 3/31/21 | 3/31/22 | 3/30/23 | 4/1/24 | 3/31/25 | 3/30/26 |
1USD in Million2USD
Estimates
Past dividends: InnoCan Pharma Corporation
| 2025-09-05 | Significant Split/Dividend | 12:00 am |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.71% | 0.8% | 27.6x | 17.08x | 10.48x | |
| 2.22% | 2.34% | 25.27x | 6.41x | 5.88x | |
| 3.33% | 3.46% | 23.1x | 144.54x | 6.26x | |
| - | - | - | - | 4.16x | |
| 1.62% | 1.72% | 25.82x | 5.72x | 5.33x | |
| 2.78% | 2.86% | 28.22x | 5.34x | 5.02x | |
| 2.86% | 2.99% | 21.36x | 6.43x | 5.74x | |
| 2.86% | 3.06% | 23.42x | 16.7x | 6.07x | |
| 2.34% | 2.39% | 19.15x | 6.24x | 5.87x | |
| Average | 2.34% | 2.45% | 24.24x | 26.06x | 6.09x | |
| Weighted average by Cap. | 2.04% | 2.15% | 25.16x | 26.41x | 6.77x |
Select your edition
All financial news and data tailored to specific country editions
